Maximus, Inc. (NYSE:MMS) Shares Bought by Entropy Technologies LP

Entropy Technologies LP lifted its stake in shares of Maximus, Inc. (NYSE:MMS) by 178.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 6,383 shares of the health services provider’s stock after buying an additional 4,088 shares during the quarter. Entropy Technologies LP’s holdings in Maximus were worth $476,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the stock. V Square Quantitative Management LLC bought a new stake in Maximus in the third quarter valued at about $25,000. UMB Bank n.a. raised its position in shares of Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 158 shares in the last quarter. Eastern Bank bought a new position in Maximus during the fourth quarter worth $29,000. R Squared Ltd bought a new stake in Maximus during the fourth quarter valued at $54,000. Finally, Quarry LP raised its holdings in shares of Maximus by 48.0% during the third quarter. Quarry LP now owns 1,017 shares of the health services provider’s stock worth $95,000 after purchasing an additional 330 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on MMS. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 6th. Raymond James upgraded Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd.

Maximus Stock Performance

MMS stock opened at $67.13 on Thursday. The company has a market capitalization of $3.83 billion, a P/E ratio of 14.44 and a beta of 0.72. The company has a quick ratio of 1.49, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a 50-day simple moving average of $74.36 and a 200 day simple moving average of $82.83. Maximus, Inc. has a fifty-two week low of $66.52 and a fifty-two week high of $93.97.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts predict that Maximus, Inc. will post 6.05 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Saturday, February 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.79%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Insider Buying and Selling

In other news, Director Raymond B. Ruddy bought 3,490 shares of the company’s stock in a transaction on Thursday, December 12th. The shares were bought at an average cost of $71.46 per share, with a total value of $249,395.40. Following the transaction, the director now directly owns 112,520 shares in the company, valued at approximately $8,040,679.20. This trade represents a 3.20 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michelle F. Link sold 2,208 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now owns 6,567 shares in the company, valued at $484,841.61. This represents a 25.16 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders bought 7,063 shares of company stock valued at $502,017. Company insiders own 1.60% of the company’s stock.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.